InMed Pharmaceuticals: Pushing Pharma Forward With Rare Cannabinoids

Benzinga 2023-03-27

Views 6

InMed Pharmaceuticals is a global leader in the development, manufacturing and commercialization of rare cannabinoids. Together with our subsidiary, BayMedica, we have unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. -InMed Pharmaceuticals

Share This Video


Download

  
Report form